Global Insights Report

Ever wondered what experts think about EGFR mutation rates and personalised treatment for advanced non-small cell lung cancer (NSCLC) in your country?

Read the latest insights from those working on the ground in lung cancer; healthcare professionals and patient group representatives from Wester Europe and North America.

This insights report helps contextualise similarities, diferences and barriers in daily practice across countries about EGFR mutation testing and personalised treatment.